The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
Open accessAbstract
Epidermal growth factor receptor (EGFR) is overexpressed in ovarian carcinomas, with direct or indirect activation of EGFR able to trigger tumour growth. We demonstrate significant activation of both signal transducer and activator of transcription (STAT)3 and its upstream activator Janus kinase (JAK)2, in high-grade ovarian carcinomas compared with normal ovaries and benign tumours. The association between STAT3 activation and migratory phenotype of ovarian cancer cells was investigated by EGF-induced epithelial-mesenchymal transition (EMT) in OVCA 433 and SKOV3 ovarian cancer cell lines. Ligand activation of EGFR induced a fibroblast-like morphology and migratory phenotype, consistent with the upregulation of mesenchyme-associated N-cadherin, vimentin and nuclear translocation of beta-catenin. This occurred concomitantly with activation of the downstream JAK2/STAT3 pathway. Both cell lines expressed interleukin-6 receptor (IL-6R), and treatment with EGF within 1 h resulted in a several-fold enhancement of mRNA expression of IL-6. Consistent with that, EGF treatment of both OVCA 433 and SKOV3 cell lines resulted in enhanced IL-6 production in the serum-free medium. Exogenous addition of IL-6 to OVCA 433 cells stimulated STAT3 activation and enhanced migration. Blocking antibodies against IL-6R inhibited IL-6 production and EGF- and IL-6-induced migration. Specific inhibition of STAT3 activation by JAK2-specific inhibitor AG490 blocked STAT3 phosphorylation, cell motility, induction of N-cadherin and vimentin expression and IL6 production. These data suggest that the activated status of STAT3 in high-grade ovarian carcinomas may occur directly through activation of EGFR or IL-6R or indirectly through induction of IL-6R signalling. Such activation of STAT3 suggests a rationale for a combination of anti-STAT3 and EGFR/IL-6R therapy to suppress the peritoneal spread of ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., & Akira, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3801 · Cited by 1,323 · cited 1×
“STAT3 is also required for mouse gastrulation, which represents a classical EMT model in embryonic development (Takeda et al, 1997).”
BackgroundGarcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C. A., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
Gao, S. P., Mark, K. G., Leslie, K., Pao, W., Motoi, N., Gerald, W. L., Travis, W. D., Bornmann, W., Veach, D., Clarkson, B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31871 · Cited by 666
Lo, H.-W., Hsu, S.-C., Xia, W., Cao, X., Shih, J.-Y., Wei, Y., Abbruzzese, J. L., Hortobagyi, G. N., & Hung, M.-C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0575 · Cited by 625
Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S., & Takeda, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4657 · Cited by 519
Transformations between epithelium and mesenchyme: Normal, pathological, and experimentally induced
Hay, E. D., & Zuk, A. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90610-x · Cited by 423
Histopathologic Grading of Ovarian Carcinoma: A Review and Proposal
Silverberg, S. G. (2000) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200001000-00003 · Cited by 351
Border-cell migration: the race is on
Montell, D. J. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1006 · Cited by 329
Silver, D. L., & Montell, D. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00607-9 · Cited by 303
(2003) · PubMed · Cited by 272
Activated Signal Transducer and Activator of Transcription (STAT) 3
Silver, D. L., Naora, H., Liu, J., Cheng, W., & Montell, D. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3959 · Cited by 252
Ahmed, N., Thompson, E. W., & Quinn, M. A. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21240 · Cited by 237
Self-citationBadache, A., & Hynes, N. E. (2001) · PubMed · Cited by 219
Ahmed, N., Maines-Bandiera, S., Quinn, M. A., Unger, W. G., Dedhar, S., & Auersperg, N. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00478.2005 · Cited by 207
Self-citationSnapShot: EGFR Signaling Pathway
Yarden, Y., & Shilo, B.-Z. (2007) · Cell · doi:10.1016/j.cell.2007.11.013 · Cited by 199
Stat3 Controls Cell Movements during Zebrafish Gastrulation
Yamashita, S., Miyagi, C., Carmany-Rampey, A., Shimizu, T., Fujii, R., Schier, A. F., & Hirano, T. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00126-0 · Cited by 178
Psyrri, A. K., Kassar, M., Yu, Z., Bamias, A., Weinberger, P., Markakis, S., Kowalski, D. P., Camp, R. L., Rimm, D. L., & Dimopoulos, M. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1436 · Cited by 166
Lim, R., Ahmed, N., Borregaard, N., Riley, C., Wafai, R., Thompson, E. W., Quinn, M. A., & Rice, G. E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22352 · Cited by 165
Self-citationEpidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis
Chan, K. S., Carbajal, S., Kiguchi, K., Clifford, J., Sano, S., & DiGiovanni, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3197 · Cited by 164
BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells
Thériault, B. L., Shepherd, T. G., Mujoomdar, M. L., & Nachtigal, M. W. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm015 · Cited by 158
Polette, M., Mestdagt, M., Bindels, S., Nawrocki‐Raby, B., Hunziker, W., Foidart, J., Birembaut, P. L., & Gilles, C. (2007) · Cells Tissues Organs · doi:10.1159/000101304 · Cited by 155
Puiffe, M., Page, C. L., Filali-Mouhim, A., Zietarska, M., Ouellet, V., Tonin, P. N., Chevrette, M., Provencher, D. M., & Mes‐Masson, A. (2007) · Neoplasia · doi:10.1593/neo.07472 · Cited by 153
Rosen, D. G., Mercado‐Uribe, I., Yang, G. S., Bast, R. C., Amin, H. M., Lai, R. L., & Liu, J. (2006) · Cancer · doi:10.1002/cncr.22293 · Cited by 133
Ahmed, N., Pansino, F., Clyde, R., Murthi, P., Quinn, M. A., Rice, G. E., Agrez, M., Mok, S. C., & Baker, M. S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.2.237 · Cited by 123
Self-citationAhmed, N., Riley, C. B., Oliva, K., Stutt, E., Rice, G. E., & Quinn, M. A. (2003) · The Journal of Pathology · doi:10.1002/path.1441 · Cited by 121
Self-citationSTAT3 signaling is activated in human skeletal muscle following acute resistance exercise
Caldow, M. K., Carey, K. A., Ward, A. C., & Cameron‐Smith, D. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01147.2006 · Cited by 118
Self-citationNightingale, J., Patel, S., Suzuki, N., Buxton, R., Takagi, K.-I., Suzuki, J., Sumi, Y., Imaizumi, A., Mason, R. M., & Zhang, Z. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000102479.92582.43 · Cited by 114
α v β 6 Integrin-A Marker for the Malignant Potential of Epithelial Ovarian Cancer
Ahmed, N., Riley, C. B., Rice, G. E., Quinn, M. A., & Baker, M. S. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205001010 · Cited by 108
Self-citationLebret, S. C., Newgreen, D. F., Thompson, E. W., & Ackland, M. L. (2007) · Breast Cancer Research · doi:10.1186/bcr1656 · Cited by 96
Chen, C., Loy, A., Cen, L., Chan, C., Hsieh, F.-C., Cheng, G., Wu, B., Qualman, S. J., Kunisada, K., Yamauchi‐Takihara, K., et al. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-111 · Cited by 91
Bagnato, A., & Rosanò, L. (2007) · Cells Tissues Organs · doi:10.1159/000101307 · Cited by 82
Rosanò, L., Castro, V. D., Spinella, F., Tortora, G., Nicotra, M. R., Natali, P. G., & Bagnato, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0883 · Cited by 82
Wang, F.-Q., So, J., Reierstad, S., & Fishman, D. A. (2005) · International Journal of Cancer · doi:10.1002/ijc.21421 · Cited by 71
Thomas, S. M., Grandis, J. R., Wentzel, A. L., Gooding, W. E., Lui, V. W. Y., & Siegfried, J. M. (2005) · Neoplasia · doi:10.1593/neo.04454 · Cited by 69
Yip, S.-C., El‐Sibai, M., Coniglio, S. J., Mouneimne, G., Eddy, R. J., Drees, B. E., Neilsen, P. O., Goswami, S. K., Symons, M. H., Condeelis, J. S., et al. (2007) · Journal of Cell Science · doi:10.1242/jcs.005298 · Cited by 66
Savarese, T. M., Campbell, C. L., McQuain, C., Mitchell, K., Guardiani, R., Quesenberry, P. J., & Nelson, B. E. (2002) · Cytokine · doi:10.1006/cyto.2002.1022 · Cited by 64
Ahmed, N., Riley, C. B., Oliva, K., Rice, G. E., & Quinn, M. A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602495 · Cited by 63
Self-citationZinc transporter LIV-1: a link between cellular development and cancer progression
Taylor, K. M., Hiscox, S., & Nicholson, R. I. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.10.003 · Cited by 63
Menstrual effluent induces epithelial-mesenchymal transitions in mesothelial cells
DEMİR, A. (2003) · Human Reproduction · doi:10.1093/humrep/deh042 · Cited by 52
Differential expression and activation of Stat3 during mouse embryo implantation and decidualization
Teng, C., Diao, H., Ma, X., Xu, L., & Yang, Z. (2004) · Molecular Reproduction and Development · doi:10.1002/mrd.20149 · Cited by 49
Intracellular Proteins and Mechanisms Involved in the Control of gp130/JAK/STAT Cytokine Signaling
Nagashima, A., & Arzt, E. (2004) · IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology · doi:10.1080/15216540410001668064 · Cited by 47
Involvement of JAK2 upstream of the PI 3-kinase in cell–cell adhesion regulation by gastrin
Ferrand, A., Kowalski‐Chauvel, A., Bertrand, C., Pradayrol, L., Fourmy, D., Dufresne, M., & Seva, C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.037 · Cited by 41
Cited by
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Marvel, D., & Gabrilovich, D. I. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80005 · Cited by 1,050
Dynamic EMT: a multi‐tool for tumor progression
Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P. (2021) · The EMBO Journal · doi:10.15252/embj.2021108647 · Cited by 761
EMT and inflammation: inseparable actors of cancer progression
Suarez‐Carmona, M., Lesage, J., Cataldo, D., & Gilles, C. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12095 · Cited by 566
Metadata
- Authors
- Colomiere, M., Ward, A. C., Riley, C., Trenerry, M. K., Cameron-Smith, D., Findlay, J., Ackland, L., & Ahmed, N.
- Venue
- British Journal of Cancer
- Published
- 2008-12-16
- Volume
- 100
- Issue
- 1
- Pages
- 134-144
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2053271495
- Cited by
- 320
- References
- 43
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.